Lamb, Lawrence S <br/><br/>
Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy.  [electronic resource] 

 -  PloS one  2013 
 - e51805 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0051805  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Brain Neoplasms--immunology<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Cytotoxicity, Immunologic--drug effects<br/>Dacarbazine--analogs & derivatives<br/>Diphosphonates--pharmacology<br/>Drug Resistance, Neoplasm--drug effects<br/>Flow Cytometry<br/>GPI-Linked Proteins--immunology<br/>Genetic Engineering<br/>Genetic Vectors--genetics<br/>Glioblastoma--immunology<br/>Humans<br/>Imidazoles--pharmacology<br/>Intercellular Signaling Peptides and Proteins--immunology<br/>Interleukin-2--pharmacology<br/>Lentivirus--genetics<br/>O(6)-Methylguanine-DNA Methyltransferase--genetics<br/>Receptors, Antigen, T-Cell, gamma-delta--immunology<br/>T-Lymphocytes--immunology<br/>Temozolomide<br/>Zoledronic Acid